|
시장보고서
상품코드
2045927
핵산 샘플 조제 시장 - 산업 규모, 점유율, 동향, 기회와 예측 : 제품별, 기술별, 치료 영역별, 용도별, 최종 사용자별, 지역별 및 경쟁(2021-2031년)Nucleic Acid Sample Preparation Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Product, By Technology, By Therapeutic Area, By Application, By End Users, By Region & Competition, 2021-2031F |
||||||
세계의 핵산 샘플 조제 시장은 2025년 29억 9,000만 달러에서 2031년까지 44억 1,000만 달러로 확대되어 CAGR 6.69%를 달성할 것으로 예측됩니다.
이 시장은 생물학적 샘플에서 DNA와 RNA를 추출, 분리, 정제하여 증폭 및 시퀀싱과 같은 중요한 다운스트림 분석 용도를 위한 고품질 재료를 얻는 데 초점을 맞추었습니다.
| 시장 개요 | |
|---|---|
| 예측 기간 | 2027-2031년 |
| 시장 규모 : 2025년 | 29억 9,000만 달러 |
| 시장 규모 : 2031년 | 44억 1,000만 달러 |
| CAGR : 2026-2031년 | 6.69% |
| 가장 성장이 현저한 부문 | 유전체학 |
| 최대 시장 | 북미 |
시장 성장 촉진요인
이 확대의 주요 요인으로는 감염과 암 발생률 증가를 들 수 있습니다. 이에 따라 광범위한 분자진단 검사가 요구되고 있으며, 정확한 유전체 프로파일링을 위해 신뢰할 수 있는 고순도 핵산 추출을 필요로 하는 정밀의학(Precision Medicine) 분야가 빠르게 발전하고 있습니다. 2024년 임상 개발 중인 의약품이 8,000여 종에 달해 바이오 의약품 연구에서 시료 처리에 대한 수요가 급증할 것으로 예측됩니다. 또한, 차세대 시퀀싱 및 분자진단의 채택 확대로 인해 액체 생검과 같은 분야에서 신뢰할 수 있는 데이터를 생성하기 위해 추출된 핵산에 대한 엄격한 품질 기준이 부과되고 있으며, 이는 시장 성장을 가속하고 있습니다.
시장의 과제
이러한 견고한 성장 요인에도 불구하고, 세계 핵산 시료 준비 시장은 자동화된 핵산 추출 플랫폼에 필요한 막대한 자본 투자로 인해 큰 장벽에 직면해 있습니다. 이러한 막대한 초기 비용은 소규모 연구소나 진단센터의 장벽이 되어 효율성이 낮고 노동 집약적인 수동 추출 방법에 의존할 수밖에 없는 경우가 많습니다. 이러한 예산상의 제약은 선진 기술 시장 침투를 직접적으로 제한하고, 그 도입을 자금력이 있는 대규모 기준검사기관에 집중시키고 있습니다. 미국병원협회(AHA)의 2025년 조사에 따르면, 의료 관리자의 94%가 지속적인 재정적 압박으로 인해 장비 업그레이드를 연기할 것으로 예상하고 있으며, 이러한 자본 프로젝트의 광범위한 연기가 유전체 프로파일링 및 진단 검사 확대에 필수적인 최신 자동화 워크플로우에 대한 투자를 촉진하는 것이 아니라 촉진하는 것이 아니라 구형 장비의 수명주기를 연장시킴으로써 시장 발전을 저해하고 있다는 점을 강조하고 있습니다.
시장 동향
이러한 성장을 보완하기 위해 시장에서는 자동 액체 취급 워크스테이션의 도입이 증가하고 있습니다. 이는 핵산 수율을 표준화하고 수작업을 줄여 재현성과 운영 효율성을 향상시킵니다. 또한, 면역학 및 공간생물학 분야의 고도화된 응용을 위해 개별 세포에서 유전물질을 분리하는 데 필수적인 단일 세포 유전체학용 고정밀 키트 개발도 진행 중입니다.
자주 묻는 질문
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 소리
제5장 세계 핵산 샘플 조제 시장 전망
제6장 북미 핵산 샘플 조제 시장 전망
제7장 유럽 핵산 샘플 조제 시장 전망
제8장 아시아태평양 핵산 샘플 조제 시장 전망
제9장 중동 및 아프리카 핵산 샘플 조제 시장 전망
제10장 남미 핵산 샘플 조제 시장 전망
제11장 시장 역학
제12장 시장 동향과 발전
제13장 세계의 핵산 샘플 조제 시장 : SWOT 분석
제14장 Porter's Five Forces 분석
제15장 경쟁 구도
제16장 전략적 제안
제17장 회사 소개 및 면책조항
JHS 26.06.02The Global Nucleic Acid Sample Preparation Market is projected to expand from USD 2.99 Billion in 2025 to USD 4.41 Billion by 2031, achieving a 6.69% Compound Annual Growth Rate. This market centers on the extraction, isolation, and purification of DNA and RNA from biological samples to yield high-quality material for critical downstream analytical uses like amplification and sequencing.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 2.99 Billion |
| Market Size 2031 | USD 4.41 Billion |
| CAGR 2026-2031 | 6.69% |
| Fastest Growing Segment | Genomics |
| Largest Market | North America |
Market Driver
Key drivers for this expansion include the rising incidence of infectious diseases and cancer, demanding extensive molecular diagnostic testing, and the burgeoning field of precision medicine, which requires reliable, high-purity nucleic acid extraction for accurate genomic profiling. The substantial demand for sample processing within biopharmaceutical research is further evidenced by over 8,000 medicines in clinical development in 2024. Furthermore, the increasing adoption of Next-Generation Sequencing and molecular diagnostics is fueling market growth by imposing stringent quality standards on extracted nucleic acids for generating reliable data in areas such as liquid biopsy.
Market Challenge
Despite these robust growth factors, the Global Nucleic Acid Sample Preparation Market faces a significant impediment due to the high capital investment required for automated nucleic acid extraction platforms. This substantial initial expenditure often proves prohibitive for smaller laboratories and diagnostic centers, which are then compelled to rely on less efficient, labor-intensive manual extraction methods. Such budgetary constraints directly limit market penetration for advanced technologies and concentrate their adoption within larger, well-funded reference laboratories. Evidence from the American Hospital Association in 2025 indicates that 94% of healthcare administrators anticipated delaying equipment upgrades due to persistent financial strain, underscoring how this widespread deferral of capital projects impedes the market by extending the lifecycle of legacy equipment rather than fostering investment in modern automated workflows essential for scaling genomic profiling and diagnostic testing.
Market Trends
Complementing this growth, the market is experiencing an increase in the adoption of automated liquid handling workstations, which enhance reproducibility and operational efficiency by standardizing nucleic acid yields and reducing manual effort, alongside the development of high-precision kits for single-cell genomics, critical for isolating genetic material from individual cells for advanced applications in immunology and spatial biology.
Key Market Players
- BGI Group
- F. Hoffmann-La Roche Ltd
- Danaher Corporation
- Eppendorf SE
- BIONEER CORPORATION
- Endress+Hauser Group Services AG
- Merck KGaA
- Norgen Biotek Corp.
- Aurora Biomed Inc.
- Agilent Technologies, Inc.
Report Scope
In this report, the Global Nucleic Acid Sample Preparation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Nucleic Acid Sample Preparation Market, By Product
- Consumables
- Systems
- Accessories & Components
Nucleic Acid Sample Preparation Market, By Technology
- Spin-Column Based Technology
- Magnetic-Bead Based Technology
- Others
Nucleic Acid Sample Preparation Market, By Therapeutic Area
- Oncology
- Infectious Disease
- Human Genetics/Population Genetics
- Others
Nucleic Acid Sample Preparation Market, By Application
- Genomics
- Proteomics
- Others
Nucleic Acid Sample Preparation Market, By End Users
- Academic and Research Institutions
- Pharmaceutical and Biotechnology Companies
- Clinical and Diagnostic Laboratories
- Other
Nucleic Acid Sample Preparation Market, By Region
- North America
- United States
- Canada
- Mexico
- Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Nucleic Acid Sample Preparation Market.
Available Customizations:
Global Nucleic Acid Sample Preparation Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
- 1.1. Market Definition
- 1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations
2. Research Methodology
- 2.1. Objective of the Study
- 2.2. Baseline Methodology
- 2.3. Key Industry Partners
- 2.4. Major Association and Secondary Sources
- 2.5. Forecasting Methodology
- 2.6. Data Triangulation & Validation
- 2.7. Assumptions and Limitations
3. Executive Summary
- 3.1. Overview of the Market
- 3.2. Overview of Key Market Segmentations
- 3.3. Overview of Key Market Players
- 3.4. Overview of Key Regions/Countries
- 3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Nucleic Acid Sample Preparation Market Outlook
- 5.1. Market Size & Forecast
- 5.1.1. By Value
- 5.2. Market Share & Forecast
- 5.2.1. By Product (Consumables, Systems, Accessories & Components)
- 5.2.2. By Technology (Spin-Column Based Technology, Magnetic-Bead Based Technology, Others)
- 5.2.3. By Therapeutic Area (Oncology, Infectious Disease, Human Genetics/Population Genetics, Others)
- 5.2.4. By Application (Genomics, Proteomics, Others)
- 5.2.5. By End Users (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Other)
- 5.2.6. By Region
- 5.2.7. By Company (2025)
- 5.3. Market Map
6. North America Nucleic Acid Sample Preparation Market Outlook
- 6.1. Market Size & Forecast
- 6.1.1. By Value
- 6.2. Market Share & Forecast
- 6.2.1. By Product
- 6.2.2. By Technology
- 6.2.3. By Therapeutic Area
- 6.2.4. By Application
- 6.2.5. By End Users
- 6.2.6. By Country
- 6.3. North America: Country Analysis
- 6.3.1. United States Nucleic Acid Sample Preparation Market Outlook
- 6.3.1.1. Market Size & Forecast
- 6.3.1.1.1. By Value
- 6.3.1.2. Market Share & Forecast
- 6.3.1.2.1. By Product
- 6.3.1.2.2. By Technology
- 6.3.1.2.3. By Therapeutic Area
- 6.3.1.2.4. By Application
- 6.3.1.2.5. By End Users
- 6.3.1.1. Market Size & Forecast
- 6.3.2. Canada Nucleic Acid Sample Preparation Market Outlook
- 6.3.2.1. Market Size & Forecast
- 6.3.2.1.1. By Value
- 6.3.2.2. Market Share & Forecast
- 6.3.2.2.1. By Product
- 6.3.2.2.2. By Technology
- 6.3.2.2.3. By Therapeutic Area
- 6.3.2.2.4. By Application
- 6.3.2.2.5. By End Users
- 6.3.2.1. Market Size & Forecast
- 6.3.3. Mexico Nucleic Acid Sample Preparation Market Outlook
- 6.3.3.1. Market Size & Forecast
- 6.3.3.1.1. By Value
- 6.3.3.2. Market Share & Forecast
- 6.3.3.2.1. By Product
- 6.3.3.2.2. By Technology
- 6.3.3.2.3. By Therapeutic Area
- 6.3.3.2.4. By Application
- 6.3.3.2.5. By End Users
- 6.3.3.1. Market Size & Forecast
- 6.3.1. United States Nucleic Acid Sample Preparation Market Outlook
7. Europe Nucleic Acid Sample Preparation Market Outlook
- 7.1. Market Size & Forecast
- 7.1.1. By Value
- 7.2. Market Share & Forecast
- 7.2.1. By Product
- 7.2.2. By Technology
- 7.2.3. By Therapeutic Area
- 7.2.4. By Application
- 7.2.5. By End Users
- 7.2.6. By Country
- 7.3. Europe: Country Analysis
- 7.3.1. Germany Nucleic Acid Sample Preparation Market Outlook
- 7.3.1.1. Market Size & Forecast
- 7.3.1.1.1. By Value
- 7.3.1.2. Market Share & Forecast
- 7.3.1.2.1. By Product
- 7.3.1.2.2. By Technology
- 7.3.1.2.3. By Therapeutic Area
- 7.3.1.2.4. By Application
- 7.3.1.2.5. By End Users
- 7.3.1.1. Market Size & Forecast
- 7.3.2. France Nucleic Acid Sample Preparation Market Outlook
- 7.3.2.1. Market Size & Forecast
- 7.3.2.1.1. By Value
- 7.3.2.2. Market Share & Forecast
- 7.3.2.2.1. By Product
- 7.3.2.2.2. By Technology
- 7.3.2.2.3. By Therapeutic Area
- 7.3.2.2.4. By Application
- 7.3.2.2.5. By End Users
- 7.3.2.1. Market Size & Forecast
- 7.3.3. United Kingdom Nucleic Acid Sample Preparation Market Outlook
- 7.3.3.1. Market Size & Forecast
- 7.3.3.1.1. By Value
- 7.3.3.2. Market Share & Forecast
- 7.3.3.2.1. By Product
- 7.3.3.2.2. By Technology
- 7.3.3.2.3. By Therapeutic Area
- 7.3.3.2.4. By Application
- 7.3.3.2.5. By End Users
- 7.3.3.1. Market Size & Forecast
- 7.3.4. Italy Nucleic Acid Sample Preparation Market Outlook
- 7.3.4.1. Market Size & Forecast
- 7.3.4.1.1. By Value
- 7.3.4.2. Market Share & Forecast
- 7.3.4.2.1. By Product
- 7.3.4.2.2. By Technology
- 7.3.4.2.3. By Therapeutic Area
- 7.3.4.2.4. By Application
- 7.3.4.2.5. By End Users
- 7.3.4.1. Market Size & Forecast
- 7.3.5. Spain Nucleic Acid Sample Preparation Market Outlook
- 7.3.5.1. Market Size & Forecast
- 7.3.5.1.1. By Value
- 7.3.5.2. Market Share & Forecast
- 7.3.5.2.1. By Product
- 7.3.5.2.2. By Technology
- 7.3.5.2.3. By Therapeutic Area
- 7.3.5.2.4. By Application
- 7.3.5.2.5. By End Users
- 7.3.5.1. Market Size & Forecast
- 7.3.1. Germany Nucleic Acid Sample Preparation Market Outlook
8. Asia Pacific Nucleic Acid Sample Preparation Market Outlook
- 8.1. Market Size & Forecast
- 8.1.1. By Value
- 8.2. Market Share & Forecast
- 8.2.1. By Product
- 8.2.2. By Technology
- 8.2.3. By Therapeutic Area
- 8.2.4. By Application
- 8.2.5. By End Users
- 8.2.6. By Country
- 8.3. Asia Pacific: Country Analysis
- 8.3.1. China Nucleic Acid Sample Preparation Market Outlook
- 8.3.1.1. Market Size & Forecast
- 8.3.1.1.1. By Value
- 8.3.1.2. Market Share & Forecast
- 8.3.1.2.1. By Product
- 8.3.1.2.2. By Technology
- 8.3.1.2.3. By Therapeutic Area
- 8.3.1.2.4. By Application
- 8.3.1.2.5. By End Users
- 8.3.1.1. Market Size & Forecast
- 8.3.2. India Nucleic Acid Sample Preparation Market Outlook
- 8.3.2.1. Market Size & Forecast
- 8.3.2.1.1. By Value
- 8.3.2.2. Market Share & Forecast
- 8.3.2.2.1. By Product
- 8.3.2.2.2. By Technology
- 8.3.2.2.3. By Therapeutic Area
- 8.3.2.2.4. By Application
- 8.3.2.2.5. By End Users
- 8.3.2.1. Market Size & Forecast
- 8.3.3. Japan Nucleic Acid Sample Preparation Market Outlook
- 8.3.3.1. Market Size & Forecast
- 8.3.3.1.1. By Value
- 8.3.3.2. Market Share & Forecast
- 8.3.3.2.1. By Product
- 8.3.3.2.2. By Technology
- 8.3.3.2.3. By Therapeutic Area
- 8.3.3.2.4. By Application
- 8.3.3.2.5. By End Users
- 8.3.3.1. Market Size & Forecast
- 8.3.4. South Korea Nucleic Acid Sample Preparation Market Outlook
- 8.3.4.1. Market Size & Forecast
- 8.3.4.1.1. By Value
- 8.3.4.2. Market Share & Forecast
- 8.3.4.2.1. By Product
- 8.3.4.2.2. By Technology
- 8.3.4.2.3. By Therapeutic Area
- 8.3.4.2.4. By Application
- 8.3.4.2.5. By End Users
- 8.3.4.1. Market Size & Forecast
- 8.3.5. Australia Nucleic Acid Sample Preparation Market Outlook
- 8.3.5.1. Market Size & Forecast
- 8.3.5.1.1. By Value
- 8.3.5.2. Market Share & Forecast
- 8.3.5.2.1. By Product
- 8.3.5.2.2. By Technology
- 8.3.5.2.3. By Therapeutic Area
- 8.3.5.2.4. By Application
- 8.3.5.2.5. By End Users
- 8.3.5.1. Market Size & Forecast
- 8.3.1. China Nucleic Acid Sample Preparation Market Outlook
9. Middle East & Africa Nucleic Acid Sample Preparation Market Outlook
- 9.1. Market Size & Forecast
- 9.1.1. By Value
- 9.2. Market Share & Forecast
- 9.2.1. By Product
- 9.2.2. By Technology
- 9.2.3. By Therapeutic Area
- 9.2.4. By Application
- 9.2.5. By End Users
- 9.2.6. By Country
- 9.3. Middle East & Africa: Country Analysis
- 9.3.1. Saudi Arabia Nucleic Acid Sample Preparation Market Outlook
- 9.3.1.1. Market Size & Forecast
- 9.3.1.1.1. By Value
- 9.3.1.2. Market Share & Forecast
- 9.3.1.2.1. By Product
- 9.3.1.2.2. By Technology
- 9.3.1.2.3. By Therapeutic Area
- 9.3.1.2.4. By Application
- 9.3.1.2.5. By End Users
- 9.3.1.1. Market Size & Forecast
- 9.3.2. UAE Nucleic Acid Sample Preparation Market Outlook
- 9.3.2.1. Market Size & Forecast
- 9.3.2.1.1. By Value
- 9.3.2.2. Market Share & Forecast
- 9.3.2.2.1. By Product
- 9.3.2.2.2. By Technology
- 9.3.2.2.3. By Therapeutic Area
- 9.3.2.2.4. By Application
- 9.3.2.2.5. By End Users
- 9.3.2.1. Market Size & Forecast
- 9.3.3. South Africa Nucleic Acid Sample Preparation Market Outlook
- 9.3.3.1. Market Size & Forecast
- 9.3.3.1.1. By Value
- 9.3.3.2. Market Share & Forecast
- 9.3.3.2.1. By Product
- 9.3.3.2.2. By Technology
- 9.3.3.2.3. By Therapeutic Area
- 9.3.3.2.4. By Application
- 9.3.3.2.5. By End Users
- 9.3.3.1. Market Size & Forecast
- 9.3.1. Saudi Arabia Nucleic Acid Sample Preparation Market Outlook
10. South America Nucleic Acid Sample Preparation Market Outlook
- 10.1. Market Size & Forecast
- 10.1.1. By Value
- 10.2. Market Share & Forecast
- 10.2.1. By Product
- 10.2.2. By Technology
- 10.2.3. By Therapeutic Area
- 10.2.4. By Application
- 10.2.5. By End Users
- 10.2.6. By Country
- 10.3. South America: Country Analysis
- 10.3.1. Brazil Nucleic Acid Sample Preparation Market Outlook
- 10.3.1.1. Market Size & Forecast
- 10.3.1.1.1. By Value
- 10.3.1.2. Market Share & Forecast
- 10.3.1.2.1. By Product
- 10.3.1.2.2. By Technology
- 10.3.1.2.3. By Therapeutic Area
- 10.3.1.2.4. By Application
- 10.3.1.2.5. By End Users
- 10.3.1.1. Market Size & Forecast
- 10.3.2. Colombia Nucleic Acid Sample Preparation Market Outlook
- 10.3.2.1. Market Size & Forecast
- 10.3.2.1.1. By Value
- 10.3.2.2. Market Share & Forecast
- 10.3.2.2.1. By Product
- 10.3.2.2.2. By Technology
- 10.3.2.2.3. By Therapeutic Area
- 10.3.2.2.4. By Application
- 10.3.2.2.5. By End Users
- 10.3.2.1. Market Size & Forecast
- 10.3.3. Argentina Nucleic Acid Sample Preparation Market Outlook
- 10.3.3.1. Market Size & Forecast
- 10.3.3.1.1. By Value
- 10.3.3.2. Market Share & Forecast
- 10.3.3.2.1. By Product
- 10.3.3.2.2. By Technology
- 10.3.3.2.3. By Therapeutic Area
- 10.3.3.2.4. By Application
- 10.3.3.2.5. By End Users
- 10.3.3.1. Market Size & Forecast
- 10.3.1. Brazil Nucleic Acid Sample Preparation Market Outlook
11. Market Dynamics
- 11.1. Drivers
- 11.2. Challenges
12. Market Trends & Developments
- 12.1. Merger & Acquisition (If Any)
- 12.2. Product Launches (If Any)
- 12.3. Recent Developments
13. Global Nucleic Acid Sample Preparation Market: SWOT Analysis
14. Porter's Five Forces Analysis
- 14.1. Competition in the Industry
- 14.2. Potential of New Entrants
- 14.3. Power of Suppliers
- 14.4. Power of Customers
- 14.5. Threat of Substitute Products
15. Competitive Landscape
- 15.1. BGI Group
- 15.1.1. Business Overview
- 15.1.2. Products & Services
- 15.1.3. Recent Developments
- 15.1.4. Key Personnel
- 15.1.5. SWOT Analysis
- 15.2. F. Hoffmann-La Roche Ltd
- 15.3. Danaher Corporation
- 15.4. Eppendorf SE
- 15.5. BIONEER CORPORATION
- 15.6. Endress+Hauser Group Services AG
- 15.7. Merck KGaA
- 15.8. Norgen Biotek Corp.
- 15.9. Aurora Biomed Inc.
- 15.10. Agilent Technologies, Inc.
